Beta Bionics Funding: $333M Raised, Series E (2024)
Beta Bionics is a Healthtech company based in Irvine, California. It has raised $333M in total funding. Latest round: Series E.
Beta Bionics funding overview
Beta Bionics is a Healthtech company based in Irvine, California. Beta Bionics has raised $333M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series E announced in November 2024. The round record for Beta Bionics runs through 2024; nothing later has been disclosed. Investors on record include Dexcom, Novo Nordisk, Sands Capital, Omega Funds. 4 distinct backers are named across the disclosed rounds.
Beta Bionics at a glance
Total raised
$333M
Latest round
Series E
Latest round date
November 2024
Industry
Healthtech
Headquarters
Irvine, California
Notable investors
Dexcom, Novo Nordisk, Sands Capital, Omega Funds
Frequently asked about Beta Bionics funding
How much has Beta Bionics raised?
Beta Bionics has raised $333M in total disclosed funding across the rounds on record.
Who has invested in Beta Bionics?
Dexcom, Novo Nordisk, Sands Capital, Omega Funds are named among the investors backing Beta Bionics.
What was the latest Beta Bionics funding round?
The most recent disclosed round is a Series E, announced in November 2024.
Where is Beta Bionics based?
Beta Bionics is based in Irvine, California.
What sector does Beta Bionics operate in?
Beta Bionics is tracked under Healthtech from Irvine, California, with $333M in disclosed funding.
When did Beta Bionics last raise?
The last disclosed Beta Bionics round closed in November 2024 at Series E.
Round data for Beta Bionics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Healthtech companies in Irvine and backer lists below.
